Premium
Evaluation of skeletal muscle during calf exercise by 31‐phosphorus magnetic resonance spectroscopy in patients on statin medications
Author(s) -
Wu Jim S.,
Buettner Catherine,
Smithline Howard,
Ngo Long H.,
Greenman Robert L.
Publication year - 2011
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.21847
Subject(s) - phosphocreatine , statin , creatine kinase , medicine , creatine , myopathy , magnetic resonance imaging , skeletal muscle , endocrinology , physical therapy , cardiology , energy metabolism , radiology
Muscle pain is a common side effect of statin medications, but the cause is poorly understood. We characterized phosphocreatine (PCr) exercise recovery kinetics in 10 patients with hypercholesterolemia before and after a 4‐week regimen of statin therapy using 31‐phosphorus magnetic resonance spectroscopy ( 31 P‐MRS). 31 P spectra were obtained before, during, and after exercise on a calf flexion pedal ergometer. Creatine kinase (CK) serum levels were drawn before and after statin therapy. The mean metabolic recovery time constant in subjects increased from 28.1 s (SE = 6.5 s) to 55.4 s (SE = 7.4 s) after statin therapy. The unweighted mean of the pre/post‐recovery time difference was −27.3 s (SE = 12.4 s; P = 0.02). Pre‐ and post‐therapy CK levels were not significantly different ( P = 0.50). Metabolic recovery time in the calf is prolonged in patients after statin use. This suggests that statins impair mitochondrial oxidative function, and 31 P MRS is a potential study model for statin‐associated myopathy. Muscle Nerve, 2011
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom